Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Sunday, Incyte Announced New Results From Phase 2 Study Of Ruxolitinib Cream (Opzelura) In Hidradenitis Suppurativa, The Study Met Its Primary Endpoint, Demonstrating Significant Reduction In Abscess, Inflammatory Nodule Count Versus Vehicle Control

Author: Benzinga Newsdesk | March 11, 2024 05:34am

Posted In: INCY